Drug Profile
Research programme: chloride ion channel antagonists - Nordic Bioscience
Alternative Names: NS 3736Latest Information Update: 02 Dec 2013
Price :
$50
*
At a glance
- Originator NeuroSearch; Nordic Bioscience
- Developer Nordic Bioscience
- Class
- Mechanism of Action Chloride channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Postmenopausal osteoporosis
Most Recent Events
- 15 Sep 2009 Preclinical trials in Postmenopausal osteoporosis in Denmark (unspecified route)
- 13 Jul 2006 Discontinued - Preclinical for Postmenopausal osteoporosis in Denmark (unspecified route)
- 16 Jun 2004 Data presented at the World Congress on Osteoporosis (WCO-2004) have been added to the Musculoskeletal disorders pharmacodynamics section